home / stock / aytu / aytu short
Short Information | Aytu BioPharma Inc. (NASDAQ:AYTU)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 116,267 |
Total Actual Volume | 495,733 |
Short Trends | |
---|---|
Cover Days | 16 |
Short Days | 0 |
No Change Days | 4 |
Averages | |
---|---|
Average Short Volume | 5,813 |
Average Short Percentage | 18.42% |
Is there a AYTU Short Squeeze or Breakout about to happen?
See the AYTU Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-03-2024 | $2.855 | $2.85 | $2.91 | $2.8 | 2,117 | 26 | 1.23% |
07-02-2024 | $2.798 | $2.86 | $2.92 | $2.7901 | 19,145 | 6,934 | 36.22% |
07-01-2024 | $2.89 | $2.85 | $2.905 | $2.75 | 26,543 | 9,338 | 35.18% |
06-28-2024 | $2.84 | $2.92 | $2.94 | $2.84 | 19,115 | 5,085 | 26.6% |
06-27-2024 | $2.89 | $2.86 | $2.9119 | $2.86 | 8,569 | 336 | 3.92% |
06-26-2024 | $2.97 | $2.88 | $2.97 | $2.86 | 7,243 | 321 | 4.43% |
06-25-2024 | $2.94 | $2.99 | $2.99 | $2.91 | 28,914 | 9,767 | 33.78% |
06-24-2024 | $2.965 | $2.95 | $2.965 | $2.835 | 25,492 | 4,799 | 18.83% |
06-21-2024 | $2.93 | $2.91 | $2.93 | $2.78 | 29,818 | 2,637 | 8.84% |
06-20-2024 | $2.87 | $2.8 | $2.9449 | $2.78 | 20,545 | 1,552 | 7.55% |
06-18-2024 | $2.99 | $2.85 | $2.99 | $2.77 | 47,674 | 16,874 | 35.39% |
06-17-2024 | $2.86 | $2.81 | $2.9087 | $2.78 | 13,925 | 1,103 | 7.92% |
06-14-2024 | $2.88 | $2.85 | $2.9 | $2.78 | 33,068 | 5,030 | 15.21% |
06-13-2024 | $3.09 | $2.87 | $3.16 | $2.83 | 30,174 | 3,638 | 12.06% |
06-12-2024 | $3.08 | $2.93 | $3.08 | $2.88 | 79,966 | 18,904 | 23.64% |
06-11-2024 | $3.0347 | $3.0345 | $3.0347 | $3.0345 | 2,650 | 27 | 1.02% |
06-10-2024 | $3.04 | $3.09 | $3.1 | $3 | 25,223 | 8,144 | 32.29% |
06-07-2024 | $3.12 | $3.03 | $3.19 | $3.02 | 47,149 | 19,395 | 41.14% |
06-06-2024 | $3.17 | $3.19 | $3.2099 | $3.07 | 20,302 | 811 | 3.99% |
06-05-2024 | $3.16 | $3.2 | $3.2 | $3.1 | 8,101 | 1,546 | 19.08% |
News, Short Squeeze, Breakout and More Instantly...
Company receives proceeds of $3.5 million through exercise of warrants, a portion of which was used to pay down debt Interest rate on new $13.0 million term loan reduced by approximately 350 basis points today, potentially saving the Company $1.3 million over the life of the term loan T...
Phoenix, Arizona and New York, New York--(Newsfile Corp. - May 29, 2024) - Lytham Partners, a leading investor relations and corporate access firm, today announced the schedule for its Spring 2024 Investor Conference taking place virtually on May 30, 2024. More than 40 companies will be available...
DENVER, CO / ACCESSWIRE / May 23, 2024 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that Josh Disbrow, CEO, will participate in a webcasted fireside chat and host one-on-one meetings with inv...